Influence of host genetics on the severity of coccidioidomycosis

Emerging Infectious Diseases

Volumn 5, Issue 5, 1999, Pages 672-680

  Louie, Leslie ^a   Ng, Susanna ^a   Hajjeh, Rana ^b   Johnson, Royce ^c   Vugia, Duc ^d   Werner, S Benson ^d   Talbot, Ronald ^e   Klitz, William ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c KERN MEDICAL CENTER   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^e Kern County Department of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; BLOOD GROUP ABO SYSTEM; CAUCASIAN; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC GROUP; HOST RESISTANCE; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; NEGRO; UNITED STATES;

EID: 0032747932     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0505.990508     Document Type: Article

References (41)

1. Pappagianis D, Sun RK, Werner SB, Rutherford GW, Elsea RW, Miller GB, et al. Coccidioidomycosis - United States, 1991-1992. MMWR Morb Mortal Wkly Rep 1993;42:21-4.
2. Pappagianis D. Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clin Infect Dis 1994;19 Suppl 1:S14-8.
3. Pappagianis D, Feldman G, Billimek M, Mascola L, Werner SB, Jackson RJ, et al. Coccidioidomycosis following the Northridge earthquake - California, 1994. MMWR Morb Mortal Wkly Rep 1994;43:194-5.
4. Jinadu BA, Welch G, Talbot R, Caldwell J, Johnson R, Blume D, et al. Coccidioidomycosis - California, 1991-1993 MMWR Morb Mortal Wkly Rep 1994;43:421-3.
5. Schneider E, Hajjeh RA, Spiegel RA, Jibson RW, Harp EL, Marshall GA, et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA 1997;277:904-8.
6. Galgiani JN, Cohen IM. Coccidioidomycosis in renal transplant recipients: blood group, diabetes, and tissue type as risk factors. Current chemotherapy and infectious disease. Proceedings of the 11th International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston (MA): American Society for Microbiology; 1980. p. 992-4.
7. Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med 1982;142:489-94.
8. Galgiani JN. Coccidioidomycosis. West J Med 1993;159:153-71.
9. Pappagianis D. Epidemiology of coccidioidomycosis. In: McGinnis M, editor. Current topics in medical mycology. New York: Springer Verlag; 1988. p. 199-238.
10. Flynn NM, Hoeprich PD, Kawachi MM, Lee KK, Lawrence RM, Goldstein E, et al. An unusual outbreak of windborne coccidioidomycosis. N Engl J Med 1979;301:358-61.
11. Rosenstein N, Werner SB, Kao A, Emery K, Rogers D, Vugia D, et al. Coccidioidomycosis: risk factors for severe pulmonary and disseminated disease. Kern County, California. Proceedings of the 35th Annual Meeting of the Infectious Diseases Society of America; 1997 Sept 13-17; San Francisco, California; 1997.
12. Catanzaro A, Spitler LE, Moser KM. Cellular immune response in coccidioidomycosis. Cell Immunol 1975;15:360-71.
13. Cox RA, Vivas JR, Gross A, Lecara G, Miller E, Brummer E. In vivo and in vitro cell-mediated responses in coccidioidomycosis. I. Immunologic responses of persons with primary, asymptomatic infections. American Review of Respiratory Disease 1976;114:937-43.
14. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989;46:111-47.
15. Scheer M, Opelz G, Terasaki P, Hewitt W. The association of disseminated coccidioidomycosis and histocompatibility type. Proceedings of the 13th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington: American Society for Microbiology; 1973.
16. Deresinski SC, Pappagianis D, Stevens DA. Association of ABO blood group and outcome of coccidioidal infection. Sabouraudia 1979,17:261-4.
17. Mourant AE, Kopec AC, Domaniewska-Sobczak K. The distribution of the human blood groups, and other polymorphisms. London: Oxford University Press; 1976. p. 230.
18. Barcellos LF. Genetic analysis of multiple sclerosis in Caucasian and Northern Chinese populations: An investigation of HLA and non-HLA loci. School of Public Health [dissertation]. Berkeley (CA): University of California; 1996.
19. Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W, et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet 1993;3:358-64.
20. Just JJ, King MC, Thomson G, Klitz W. African-American HLA class II allele and haplotype diversity. Tissue Antigens 1997;49:547-55.
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
22. Erlich H, Bugawan T, Begovich AB, Scharf S, Griffith R, Saiki R, et al. HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. Eur J Immunogenet 1991;18:33-55.
23. Carrington M, Miller T, White M, Gerrard B, Stewart C, Dean M, et al. Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism. Hum Immunol 1992;33:208-12.
24. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours Tissue Antigens 1993;41:119-34.
25. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361-72.
26. Vogel F, Motulsky AG. Human Genetics. Berlin: Springer Verlag; 1986. p. 130-1.
27. Baur MP, Danilovs J. Population genetic analysis of HLA-A, B, C, DR, and other genetic markers. In: Terasaki PI, editor. Histocompatibility testing 1980. Los Angeles: UCLA Tissue Typing Laboratory; 1980. p. 955-93.
28. Long JC, Williams RC, Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995;56:799-810.
29. U.S. Department of Health and Human Services. United States 1996-1997 health and injury chartbook. Hyattsville (MD) The Department; 1997. Pub. no. (PHS) 97-1232.
30. Race RR, Sanger R. Blood groups in man. Oxford (PA): Blackwell Scientific Publications distributed by J. B. Lippincott; 1975.
31. Reid ME, Bird GW. Associations between human red cell blood group antigens and disease. Transfus Med Rev 1990;4:47-55.
32. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229-33.
33. Gale D, Lockhart EA, Kimbell E. Studies of Coccidioides immitis. 4. The effect of previous injection with human red cell stromata of the ABO groups on infection of mice with C. immitis. J Infect Dis 1968;118:54-64.
34. Greggio NA, Cameran M, Giaquinto C, Zacchello F, Koroliuk D, Colizzi V. DNA HLA-DRB1 analysis in children of positive mothers and estimated risk of vertical HIV transmission. Dis Markers 1993;11:29-35.
35. Winchester R, Chen Y, Rose S, Selby J, Borkowsky W. Major histocompatibihty complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method. Proc Natl Acad Sci U S A 1995;92:12374-8.
36. Chen Y, Winchester R, Korber B, Gagliano J, Bryson Y, Hutto C, et al. Influence of HLA alleles on the rate of progression of vertically transmitted HFV infection in children: association of several HLA-DR13 alleles with long-term survivorship and the potential association of HLA-A*2301 with rapid progression to AIDS. Long-term survivor study. Hum Immunol 1997;55:154-62.
37. Tiwari JL, Terasaki PI, editors. HLA and disease associations. New York: Springer Verlag; 1985.
38. Serjeantson SW, Easteal S. Class II histocompatibility genes and insulin-dependent diabetes mellitus. Molecular Biology and Medicine 1989;6:219-26.
39. Kirkland TN, Finley F, Orsborn KI, Galgiani JN. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. Infect Immun 1998;66:3519-22.
40. Kirkland TN, Thomas PW, Finley F, Cole GT. Immunogenicity of a 48-kilodalton recombinant T-cell-reactive protein of Coccidioides immitis. Infect Immun 1998;66:424-31.
41. Zimmermann CR, Johnson SM, Martens GW, White AG, Zimmer BL, Pappagianis D. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect Immun 1998;66:2342-5.